Seroprevalence of Hepatitis B virus Infection by Quantitative Chemiluminescent in Tabriz (North West of Iran), 2010-2011
Novelty in Biomedicine,
Vol. 2 No. 3 (2014),
4 August 2014
,
Page 91-94
https://doi.org/10.22037/nbm.v2i3.6804
Abstract
Background: Hepatitis B is considered as one of the most common infectious diseases. The contamination of this virus has caused hygienic problems all over the world. Liver cirrhosis and hepatocellular carcinoma are most important consequences of this disease. The purpose of this study is to determine the rate of infection in Tabriz North West of Iran.
Materials and Methods: This study is carried out, on partial and short time basis between 2010 and 2011, on test results of 21421 examined individuals whom have visited clinics in Tabriz. HBsAg of the samples was analyzed with chemiluminescence apparatus and finally, SPSS software was used to conduct the statistical examination of the results.
Results: Among 21421 examined individuals (5021 cases in 2010 and 16400 cases in 2011), 594 samples (2.77%) were reported positive and 20827 samples (97.23%) were reported negative.
Conclusion: According to the results, gender was not a determining factor affecting the susceptibility of patients. Our country is endemic to this disease, so diagnostic and preventive methods are crucial, more over comprehensive national vaccination can help to noticeably reduce the infectious cases caused by the disease.
- Hepatitis B
- HBsAg
- Chemiluminescence
How to Cite
References
Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol. 2010; 58: 273-7.
Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999;12: 351-66.
Jarvis L, Cleland A, Simmonds P, Dow B, Munro M, Jordan A, et al. Screening blood donations for hepatitis C virus by polymerase chain reaction. Vox Sang. 2000; 8: 57-8.
Gerlich WH. Medical Virology of Hepatitis B: how it began and where we are now. Virol J. 2013;10: 239.
Gold E. Textbook of Human Virology. JAMA 1991; 266: 282.
Özkal P, Ilgın-Ruhi H, Akdoğan M, Elhan AH, Kaçar S, Şaşmaz N. The genotoxic effects of hepatitis B virus to host DNA. Mutagenesis. 2005;20:147-50.
Bayliss J, Nguyen T, Lesmana CRA, Bowden S, Revill P. Advances in the Molecular Diagnosis of Hepatitis B Infection: Providing Insight into the Next Generation of Disease. Seminars in liver disease 2013: Thieme. 2013;113-21.
Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med 2000; 3: 192-201.
Diepersloot RJ, van Zantvliet-van Oostrom Y, Gleaves CA. Comparison of a chemiluminescent immunoassay with two microparticle enzyme immunoassays for detection of hepatitis B virus surface antigen. Clin Diagn Lab Immunol. 2000;7: 865-6.
Weber B. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene. Expert Rev Mol Diagn. 2005; 5:75-91.
Funk M, Rosenberg D, Lok A. Worldwide epidemiology of HBeAg negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat. 2002;9: 52-61.
Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol. 2012; 4: 74.
Ismail N, Fish GE, Smith MB. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol. 2004;42:610-7.
Sablon E, Shapiro F. Advances in Molecular Diagnosis of HBV Infection and Drug Resistance. Int J Med Sci. 2004;2:8-16.
Maynard J. Hepatitis B: global importance and need for control. Vaccine. 1990;8: S18-S20.
Ghorbanalizadegan M, Ranjbar R, Ghodarzi Z. Comparison of immunochemiluminescence method and PCR for detection of Hepatitis B, in Baghitallah hospital laboratory patients. J Ilam Uni Med Sci. 2007;15:1-6.
Mohammadalizadeh A, Ranjbar M, Hatami S. Virologic characteristics of chronic hepatitis B. Pajouhesh Dar Pezeshki. 2005;29:153-156.
Azarhoush R, Borghei N, Vakili M, Latifi K. Serologic immunity of Gorgan medical personnels against hepatitis B. J Gorgan Uni Med Sci. 2006;8:39-44.
Liaw YF. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review. Hepatology. 2011;53:2121-9.
Chen D, Kaplan L, Liu Q. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers. Clinica chimica acta. 2005;355:41-5.
Aminzadeh Z, Aghazadeh Sarhangipour K. Seroepidemiology of HIV, syphilis, hepatitis B and C in intravenous drug users at Loghman Hakim hospital. Iran J Med Microbiol. 2007;1:53-56.
- Abstract Viewed: 411 times
- PDF Downloaded: 322 times